跳至主要内容
临床试验/ACTRN12609000034235
ACTRN12609000034235招募中4 期

For people with stroke, does botulinum toxin or ankle foot orthosis provide better control of knee hyperextension in the stance phase of gait?

Clinical Gait Analysis Service0 个研究点目标入组 15 人开始时间: 2009年1月19日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • People with stroke affecting one side of the body;
  • Passive dorsiflexion less than plantigrade;
  • dynamic range of gastrocnemius greater than 15 degrees;
  • knee hyperextension more than 0 degrees in mid-stance;
  • able to walk more than 400 metres without assistance;
  • agree to injections +/- ankle foot orthosis
  • agree to repeat assessments.

排除标准

  • Participants will have no other neurological, cardiothoracic, orthopaedic or psychological condition affecting walking ability. Other exclusion criteria include: incompetence to provide informed consent; known contraindications to botulinum toxin, including sensitivity, infection and pregancy; participants who have received BoNT-A or phenol injections for the treatment of increased tone within the previous 6 months.

研究者

发起方
Clinical Gait Analysis Service

相似试验